QAM
QCI Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-29,539
| Closed | -$18.4M | – | 140 |
|
|
2020
Q2 | $18.4M | Buy |
29,539
+4
| +0% | +$2.5K | 1.44% | 34 |
|
|
2020
Q1 | $14.4M | Sell |
29,535
-20,715
| -41% | -$10.1M | 1.41% | 36 |
|
|
2019
Q4 | $18.9M | Sell |
50,250
-2,981
| -6% | -$1.12M | 1.63% | 30 |
|
|
2019
Q3 | $14.8M | Buy |
53,231
+3,581
| +7% | +$993K | 1.33% | 39 |
|
|
2019
Q2 | $15.5M | Buy |
49,650
+4,131
| +9% | +$1.29M | 1.48% | 36 |
|
|
2019
Q1 | $18.7M | Buy |
45,519
+3,791
| +9% | +$1.56M | 1.84% | 22 |
|
|
2018
Q4 | $15.6M | Buy |
41,728
+397
| +1% | +$148K | 1.71% | 23 |
|
|
2018
Q3 | $16.7M | Buy |
41,331
+595
| +1% | +$240K | 1.58% | 28 |
|
|
2018
Q2 | $14.1M | Buy |
40,736
+1,116
| +3% | +$385K | 1.41% | 40 |
|
|
2018
Q1 | $13.6M | Buy |
+39,620
| New | +$13.6M | 1.45% | 41 |
|
|
2017
Q2 | – | Sell |
-20
| Closed | -$8K | – | 678 |
|
|
2017
Q1 | $8K | Buy |
+20
| New | +$8K | ﹤0.01% | 412 |
|